版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
Thyroidcasepresentation1609398DepartmentofPathology,HubeiCancerHospitalWangManxiang,
DengYunte
2017.3.25-26Nanjing49-yfemale,sufferedintermittentpaininherrightlegforamonth,andpresentedwithneckmassfor3days.Nopasthistoryofmajordisease.Ultrasoundexamination
showeddiffuseenlargementofbilateralthyroidglandswithmultiplenodules
andcalcification;bilateralneckandsupraclavicularlymphnodeswerefound.Clinicaldiagnosis:thyroidcarcinoma.Surgicaloperation:totalthyroidectomyandbilateralnecklymphnodesdissection.GrossexaminationTheleftandrightthyroidlobes:5*4*2cmand4.5*4*2cm,respectively,whichappearedtanandpartiallywhiteincolor;Dozensofcentralandlaterallymphnodes:1.2cmto3.5*2*1.5cminsize;MicroscopicViewABApseudopapillaryBYourdiagnonsis?IHCCK7CK19TTF-1TGPAX-8NapsinAIHC:Positive:CK7、CK19、TTF-1、NapsinA;Negative:TG、PAX-8、CD56、Syn、CgA、BRAF(V600E);Focalpositive:CK5/6、P63、Vimentin、HBME-1;KI-67(LI:50%)Molecularexamination:EGFR-wt;ALK-negDiagnonsisThyroidmetastasisfromlungadenocarcinoma;lymphnodes(41/41)showingthepresenceoftumor.Importantmorphologichints:thediffuseinfiltratinggrowthpatternoftumorcellsbetweennormalthyroidglands;notransformationbetweenthetwocomponents.manytumorcellsshowninthelymphaticvessels;micropapillaryclusterswithoutground-glassnucleiandnuclearinclu-sions.Immunophenotype:Positive:CK7、CK19、TTF-1、NapsinA;Negative:TG、PAX-8ClinicalandImagingfindings.
Differentialdiagnonsis
VSprimaryanaplasticcarcinomaTumornestsinvadeintonormalthyroidglandsdiffusely,butnotreplace/destroythenormalstructureofglands;Alotofcanceremboluscanbefoundinthetissue;Therearenodifferentiatedcomponentssuchaspapillarycarcinomaorfollicularcarcinomaalthoughwithwidelysampling;IHCShowsTTF-1、NapsinA(+)andPAX-8、TG(-);CTrevealedpulmonarymasses.So,primarythyriodanaplasticcarcinomacanbeexcluded.Butsometimes,itisreallydifficulttodistinguishmetastasesfromprimarymalignancies.Then,pray!ThevascularinvasionofthyroidanaplasticcarcinomaAnewlycase
H17017965-ymaleTendaysafterthyroidectomy。PET-CTdetectionofbilateralneck,supraclavicular,
mediastinal,righthilarandretroperitoneal
lymphnodesmetastases;nootherabnormalities.OriginalIHCPostive:CK7、CEA;Negtive:TG、TTF-1、CT、CK5/6、P63、CK20、SynOriginalDiagnosis:Thyroidpoorlydifferentiatedcarcinoma?Contactwiththeclinicianandpatient’swife;Dogastroscopyexamination;Addseveralimmunohistochemistrymarkers.BiopsyofgastroesophagealjunctionIHCCDH17VillinCK7Pax-8TTF-1TGPostive:Villin、CDH17、CK7、P53、CEA;Ki-67(Li:50%)Negtive:CK5/6、P63、PAX-8、TTF-1、TG、Her-2AdditionalIHCforthyroidlesionsPostive:Villin、CDH17、CEA;Negtive:PAX-8、TG、TTF-1、NapsinAVillinCDH17CK7Pax-8TTF-1TGGastroesophagealadenocarcinoma.Thyroidpoorlydifferentiatedcarcinoma,whichmetastasizesfromgastriccarcinoma,accordingtotheclinicalandimmunohistochemicalfindings.FinalDiagnosis[1]ChungAY,etal.Metastasestothethyroid:areviewoftheliterature
fromthelastdecade.Thyroid.2012;22:258–68.
[2]M.K.Nakhjavani,etal.Metastasistothethyroidgland:areportof43
cases.Cancer,1997;79:574–578.
Metastasistothyroidglandisuncommon,withreportedincidencesrangingfrom1.4to3%ofallpatientswhohadthyroidectomybecauseofmalignanttumor[1].Butinautopsystudieswhodiedofwidespreadmetastaticdisease,theincidenceisupto24%[2].Themostcommonmalignanciesmetastasizetothethyroidarerenalcell,colorectal,lungandbreastcarcinomas[1].Literaturereview(what)Althoughthethyroidglandhasarichvascularsupply,fewmetastatictumorsoccurbecauseoffastarterialflow,highoxygensaturationandiodinecontentofthethyroidglandsthatmayinhibitthegrowthofmalignantcells.Metastasisoftenoccurredinthyroidglandswithabnormalities,suchasneoplasmorbenignconditionswhichmayhavedecreasedbloodsupply,decreasedoxygenandiodinecontentandthusismorevulnerabletometastaticmalignancy.(why)ChungAY,etal.Metastasestothethyroid:areviewoftheliterature
fromthelastdecade.Thyroid.2012;22:258–68.
Misdiagnosisiscommonbecauseitisdifficulttodistinguishuncommonmetastasesfromprimarymalignancies,especiallyinapatientwithnopasthistoryofanymalignancy.(how)Ca
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年海南金融控股股份有限公司招聘筆試參考題庫(kù)含答案解析
- 2025年浙江路建交通工程有限公司招聘筆試參考題庫(kù)含答案解析
- 2025年重慶渝水水務(wù)機(jī)械有限公司招聘筆試參考題庫(kù)含答案解析
- 2025年粵教新版七年級(jí)生物上冊(cè)月考試卷含答案
- 2025年江蘇農(nóng)墾集團(tuán)南通有限公司招聘筆試參考題庫(kù)含答案解析
- 2025年度自動(dòng)化生產(chǎn)線(xiàn)承包裝卸改造合同3篇
- 2025年浙教新版選擇性必修3化學(xué)下冊(cè)月考試卷
- 2025年湘教新版高一語(yǔ)文上冊(cè)階段測(cè)試試卷含答案
- 2025年人教版九年級(jí)生物上冊(cè)階段測(cè)試試卷
- 2025年浙教版七年級(jí)地理上冊(cè)月考試卷含答案
- (正式版)SJT 11449-2024 集中空調(diào)電子計(jì)費(fèi)信息系統(tǒng)工程技術(shù)規(guī)范
- 廣州綠色金融發(fā)展現(xiàn)狀及對(duì)策的研究
- 《近現(xiàn)代史》義和團(tuán)運(yùn)動(dòng)
- 人教版四年級(jí)上冊(cè)加減乘除四則混合運(yùn)算300題及答案
- 合成生物學(xué)技術(shù)在生物制藥中的應(yīng)用
- 消化系統(tǒng)疾病的負(fù)性情緒與心理護(hù)理
- 高考語(yǔ)文文學(xué)類(lèi)閱讀分類(lèi)訓(xùn)練:戲劇類(lèi)(含答案)
- 協(xié)會(huì)監(jiān)事會(huì)工作報(bào)告大全(12篇)
- 灰壩施工組織設(shè)計(jì)
- WS-T 813-2023 手術(shù)部位標(biāo)識(shí)標(biāo)準(zhǔn)
- 同意更改小孩名字協(xié)議書(shū)
評(píng)論
0/150
提交評(píng)論